Ferraro, Pietro Manuel
 Distribuzione geografica
Continente #
NA - Nord America 6.366
AS - Asia 5.472
EU - Europa 4.541
SA - Sud America 1.217
AF - Africa 210
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 16
Totale 17.847
Nazione #
US - Stati Uniti d'America 6.208
SG - Singapore 2.369
CN - Cina 1.372
BR - Brasile 1.009
SE - Svezia 812
DE - Germania 720
FR - Francia 622
IT - Italia 594
VN - Vietnam 573
PL - Polonia 502
IE - Irlanda 282
UA - Ucraina 260
IN - India 208
ID - Indonesia 193
FI - Finlandia 167
GB - Regno Unito 158
RU - Federazione Russa 156
TR - Turchia 132
HK - Hong Kong 104
JP - Giappone 97
BD - Bangladesh 83
IQ - Iraq 72
CI - Costa d'Avorio 69
CA - Canada 66
AR - Argentina 62
BE - Belgio 53
MX - Messico 51
ZA - Sudafrica 42
NL - Olanda 41
EC - Ecuador 37
AT - Austria 32
PK - Pakistan 30
SA - Arabia Saudita 28
CO - Colombia 26
VE - Venezuela 26
MA - Marocco 25
IR - Iran 24
ES - Italia 22
PY - Paraguay 21
AU - Australia 20
CZ - Repubblica Ceca 19
CH - Svizzera 18
KR - Corea 17
UZ - Uzbekistan 16
AZ - Azerbaigian 15
JO - Giordania 14
PE - Perù 14
TW - Taiwan 13
CL - Cile 12
KE - Kenya 12
RO - Romania 12
DZ - Algeria 11
EG - Egitto 11
LT - Lituania 11
PH - Filippine 11
AL - Albania 10
IL - Israele 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
BG - Bulgaria 9
EU - Europa 9
LB - Libano 8
MY - Malesia 8
A2 - ???statistics.table.value.countryCode.A2??? 7
CR - Costa Rica 7
JM - Giamaica 7
KH - Cambogia 7
KZ - Kazakistan 7
PT - Portogallo 7
TH - Thailandia 7
GR - Grecia 6
HU - Ungheria 6
NP - Nepal 6
DO - Repubblica Dominicana 5
GE - Georgia 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
BO - Bolivia 4
HN - Honduras 4
KG - Kirghizistan 4
PA - Panama 4
RS - Serbia 4
SN - Senegal 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
BH - Bahrain 3
CY - Cipro 3
ET - Etiopia 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
GT - Guatemala 2
Totale 17.805
Città #
Singapore 1.221
Chandler 875
Ashburn 606
San Jose 487
Beijing 344
Kraków 327
Dublin 275
Jacksonville 217
Ho Chi Minh City 197
San Mateo 186
Ann Arbor 185
New York 182
Wilmington 182
Warsaw 171
Los Angeles 168
Jakarta 163
Nanjing 157
Hangzhou 154
Hanoi 151
Lauterbourg 137
Boston 120
Rome 120
Dallas 110
Hong Kong 95
The Dalles 95
Frankfurt am Main 90
São Paulo 90
Tokyo 90
Woodbridge 89
Milan 86
Dearborn 85
Fairfield 83
Princeton 77
Moscow 76
Hefei 74
Houston 73
Lawrence 70
Abidjan 69
Izmir 69
Helsinki 61
Redwood City 57
Seattle 53
Brussels 51
Munich 49
Chicago 48
Bremen 46
Santa Clara 46
Marseille 45
Nanchang 45
Boardman 44
Buffalo 41
Mountain View 39
Cattolica 38
Shenyang 36
Da Nang 35
Regensburg 35
Haiphong 34
Falls Church 33
Orem 32
Paris 32
Norwalk 29
Redmond 29
Shanghai 29
Augusta 27
Toronto 27
Dhaka 26
Hebei 26
Andover 25
Council Bluffs 25
Nuremberg 25
London 23
Tianjin 22
Busto Arsizio 21
Chennai 21
Kunming 21
Denver 20
Rio de Janeiro 20
San Francisco 20
Belo Horizonte 19
Brooklyn 19
Detroit 19
Jiaxing 19
Johannesburg 19
Kish 19
Vienna 18
Brasília 17
Düsseldorf 17
Lappeenranta 17
Montreal 17
Baghdad 16
Erbil 16
Guangzhou 16
Guayaquil 16
Phoenix 16
Poplar 16
Tashkent 16
Amsterdam 15
Brno 15
Cambridge 15
Changsha 15
Totale 9.754
Nome #
New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors 447
LOW LEVEL EXPOSURE TO CADMIUM INCREASES THE RISK OF CHRONIC KIDNEY DISEASE: ANALYSIS OF THE NHANES 1999-2006. 296
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 218
Characterization of the Protein Components of Matrix Stones Sheds Light on S100-A8 and S100-A9 Relevance in the Inflammatory Pathogenesis of These Rare Renal Calculi 215
Small intestinal bacterial overgrowth and intestinal permeability. 210
Mediterranean diet adherence and risk of incident kidney stones 193
A Specific Urinary Amino Acid Profile Characterizes People with Kidney Stones 190
Regression of endothelial dysfunction in patients with endometriosis after surgical treatment: a 2-year follow-up study 187
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes 187
Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial 176
When to suspect a genetic disorder in a patient with renal stones, and why 174
Endothelial dysfunction but not increased carotid intima-media thickness in young European women with endometriosis 172
FT-IR Analysis of Urinary Stones: A Helpful Tool for Clinician Comparison with the Chemical Spot Test, 172
Inflammatory Cytokines Associated With Failure of Lower-Extremity Endovascular Revascularization (LER): A Prospective Study of a Population With Diabetes. 171
Ayurvedic medicine and NADPH oxidase: a possible approach to the prevention of ESRD in hyperoxaluria. 170
Increased B-cell workload modulates proinsulin-to-insulin ratio in humans 166
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group 165
Effects of prednisone on biomarkers of tubular damage induced by radiocontrast in interventional cardiology 163
Caffeine intake and the risk of kidney stones 159
Role of Fourier transform infrared (FT-IR) spectroscopy in the evaluation of urinary stone disease 152
Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature 151
Antibiotic Use and Risk of Incident Kidney Stones in Female Nurses 151
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 147
Cadmium Exposure and Kidney Stone Formation in the General Population An Analysis of the National Health and Nutrition Examination Survey III Data 146
Dietary Protein and Potassium, Diet-Dependent Net Acid Load, and Risk of Incident Kidney Stones 146
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 145
A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH) 144
Neutrophil gelatinase-associated lipocalin (NGAL) value changes before and after shock wave lithotripsy 144
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 143
EFFECT OF WATER COMPOSITION AND TIMING OF INGESTION ON URINARY LITHOGENIC PROFILE IN HEALTHY VOLUNTEERS - A RANDOMIZED CROSSOVER TRIAL 143
Randall's plaques, plugs and the clinical workup of the renal stone patient 142
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass 142
Stone composition and vascular calcifications in patients with nephrolithiasis 140
Effect of water composition and timing of ingestion on urinary lithogenic profile in healthy volunteers: a randomized crossover trial 140
Hyperchloremia and acute kidney injury: a retrospective observational cohort study on a general mixed medical-surgical not ICU-hospitalized population 136
A STARD-compliant prediction model for diagnosing thrombotic microangiopathies 135
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan 134
[Hyponatremia: practical approach to diagnosis and treatment] 132
The Risk of Chronic Kidney Disease Associated With Urolithiasis and its Urological Treatments: a Review 132
Sodium Fluctuations and Mortality in a General Hospitalized Population 132
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 131
Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD. 129
Risk of kidney stones: Influence of dietary factors, dietary patterns, and vegetarian–vegan diets 129
Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones 129
Results of a gene panel approach in a cohort of patients with incomplete distal renal tubular acidosis and nephrolithiasis 129
Total, dietary, and supplemental Vitamin C intake and risk of incident kidney stones 128
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 127
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 126
[Salvage of vascular access: a case study from the Columbus nephrology division, Rome, Italy] 126
A comparison between 24h urine collection and overnight spot urines in evaluating the risk of stone disease 126
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes 124
Which diet for calcium stone patients: A real-world approach to preventive care 124
Dietetic and lifestyle recommendations for stone formers 124
Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index 122
Bile modulates secretion of incretins and insulin: a study on human extrahepatic cholestasis 121
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes 120
A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease 120
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 119
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 119
Soda and other beverages and the risk of kidney stones 119
Changes in renal papillary density after hydration therapy in calcium stone formers 119
Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report 118
Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes 118
PREVALENCE OF CKD IN NORTHEASTERN ITALY: RESULTS OF THE INCIPE STUDY AND COMPARISON WITH NHANES. 118
Chronic pain in medullary sponge kidney: a rare and never described clinical presentation 118
TEMPORAL TREND OF CADMIUM EXPOSURE IN THE U.S. POPULATION SUGGESTS GENDER SPECIFICITIES 117
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass (vol 45, pg 291, 2016) 117
Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report 117
Prevalence of renal stones in an Italian urban population: a general practice-based study 116
Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus 116
[The Italian Registry for Therapeutic Apheresis: fifteen years of activity] 115
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 113
Assessing the Best Prognostic Score for Transcatheter Aortic Valve Implantation (from the RISPEVA Registry) 113
Recurrent Kidney Stones in a patient with Malabsorption Syndrome 113
Calcium nephrolithiasis, metabolic syndrome and the cardiovascular risk 112
[Pulmonary-renal syndromes] 112
Neutrophil-to-lymphocyte ratio but not monocyte-to-HDL cholesterol ratio nor platelet-to-lymphocyte ratio correlates with early stages of lower extremity arterial disease: An ultrasonographic study 112
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 111
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial 110
Seasonality of acute kidney injury in a tertiary hospital academic center: an observational cohort study 109
CKD prevalence varies across the European general population 108
Vitamin D Intake and the Risk of Incident Kidney Stones 106
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity 104
Randall's plaques, plugs and the clinical workup of the renal stone patient 104
A preliminary survey of practice patterns across several European kidney stone centers and a call for action in developing shared practice 103
Regression of endothelial dysfunction in patients with endometriosis after surgical treatment: a 2-year follow-up study 103
Management of Primary Hyperoxaluria Type 1 in Italy 103
Distal Renal Tubular Acidosis: ERKNet/ESPN Clinical Practice Points 103
CKD Prevalence Varies across the European General Population 102
Physical activity, energy intake, and the risk of incident kidney stones 101
Selective screening for distal renal tubular acidosis in recurrent kidney stone formers: Initial experience and comparison of the simultaneous furosemide and fludrocortisone test with the short ammonium chloride test 101
Improvement of Urinary Stones Analysis Combining Morphological Analysis and Infrared Spectroscopy 101
Angiosarcoma of an Arteriovenous Fistula for Hemodialysis in a Kidney Transplant Recipient Affected by Lowe's Syndrome 101
[Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease] 100
Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation 100
Dietary oxalate intake and kidney outcomes 100
Tubular and genetic disorders associated with kidney stones 99
Serum sodium variability and acute kidney injury: a retrospective observational cohort study on a hospitalized population 98
Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis 96
The Italian registry of therapeutic apheresis: Granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study 94
Totale 13.621
Categoria #
all - tutte 76.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 0 0 0 0 0 0 0 0 0 29 115 63
2021/20221.387 128 60 43 78 101 78 39 243 78 96 171 272
2022/20232.646 401 343 219 342 179 302 148 217 284 42 100 69
2023/20241.318 64 387 36 65 56 169 89 56 22 54 107 213
2024/20252.547 72 82 232 102 175 92 50 144 349 289 518 442
2025/20266.269 1.000 206 458 769 1.052 360 1.266 346 430 382 0 0
Totale 18.137